According to a study published in the journal Gut Microbes regular yogurt consumption may reduce the risk of colorectal cancer, particularly in tumors associated with the presence of Bifidobacterium. The research indicated that individuals who consumed yogurt at least twice a week had a 20% lower risk of developing certain types of bowel cancer.

A recent study suggests that regular yogurt consumption might be linked to a reduced risk of developing colon cancer. This finding highlights the importance of the gut microbiome and its relationship with long-term health.

Yogurt, a fermented dairy product rich in beneficial bacteria, is widely recognized for its health benefits. Research suggests it may lower the risk of conditions such as inflammatory bowel disease, Clostridium difficile infection-related diarrhea,

Regular yogurt consumption may lower colorectal cancer risk by 20% due to the presence of beneficial probiotics that support gut health.

A new study tied eating at least 2 servings of yogurt per week to a lower risk of an aggressive type of colorectal cancer.

Regular yogurt intake may lower the risk of Bifidobacterium-positive colorectal cancer, particularly in the proximal colon, but does not reduce the risk of Bifidobacterium-negative tumors. Further research is needed to confirm these findings and understand yogurt’s role in gut health and cancer prevention.

According to researchers at MGB, those who have two or more servings of yogurt weekly tend to have a reduced risk of one type of colon cancer.

Related: Could Inflammation Raise Your Colon Cancer Risk? Here’s What a New Study Says Some research has suggested that shifting your routine can help you lower your risk—whether that means enjoying a glass of milk or aiming for anti-inflammatory foods and habits.